AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2020

Oct 5, 2020

31966_dirs_2020-10-05_cff9dbac-88b9-491f-a30e-a664022fff00.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-10-01

Reporting Person: Jarrett Jennifer (Director, Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-01	Stock Option (Right to Buy)	$17.17	A	900000	Acquired	2030-09-30	Common Stock (900000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100634	Direct

Footnotes

F1: The option is exercisable in 48 equal monthly installments after October 1, 2020, subject to the Reporting Person's continued service to the Company.